You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CRL Award Disclosure
Coleman Glenn · SEC Form 4 · Filed Jun 2, 2026
Award
Calculated transaction value
$1.2M
Coleman Glenn EVP & Chief Financial Officer
Transaction date
May 29, 2026
Public filing date
Jun 2, 2026
Filing lag
Filed 4 days later
CRL daily price context
Close on/before transaction
$180.71
May 29, 2026
First close after public filing
$179.87
Jun 3, 2026
30-day return after filing
+28.25%
Through Jul 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,640 shares @ $180.71
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001100682-26-000101
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$1.2M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Charles River Laboratories International, Inc. CRL Current | Award | May 29, 2026 | $1.2M |